Author: Martin Inventius Wilbert
Publisher:
ISBN:
Category : Pharmacopoeias
Languages : en
Pages : 544
Book Description
Changes in The Pharmacopoeia and The National Formulary
NFI
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1042
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1042
Book Description
Martindale
Author: Sean C. Sweetman
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335
Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335
Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced
National Formulary
Author:
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 920
Book Description
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 920
Book Description
The International Pharmacopoeia
Author: World Health Organization
Publisher: World Health Organization
ISBN: 924156301X
Category : Medical
Languages : en
Pages : 1526
Book Description
The International Pharmacopoeia contains a collection of recommended methods for analysis and quality specifications for pharmaceutical substances, excipients and products. This new edition consolidates the texts of the five separate volumes of the third edition and includes new monographs for antiretroviral substances (didanosine, indinavir sulfate, nelfinavir mesilate, nevirapine, ritonavir, saquinovir, and saquinovir mesilate) adopted by the WHO Expert Committee on Specifications for Pharmaceutical Preparations in October 2004. It includes some additions and amendments to the general notices of the Pharmacopoeia, as well as some changes to its layout and format. Volume one contains monographs for pharmaceutical substances A to O and the General Notices; and volume two contains monographs for pharmaceutical substances P to Z, together with those for dosage forms and radiopharmaceutical preparations, the methods of analysis and reagents.
Publisher: World Health Organization
ISBN: 924156301X
Category : Medical
Languages : en
Pages : 1526
Book Description
The International Pharmacopoeia contains a collection of recommended methods for analysis and quality specifications for pharmaceutical substances, excipients and products. This new edition consolidates the texts of the five separate volumes of the third edition and includes new monographs for antiretroviral substances (didanosine, indinavir sulfate, nelfinavir mesilate, nevirapine, ritonavir, saquinovir, and saquinovir mesilate) adopted by the WHO Expert Committee on Specifications for Pharmaceutical Preparations in October 2004. It includes some additions and amendments to the general notices of the Pharmacopoeia, as well as some changes to its layout and format. Volume one contains monographs for pharmaceutical substances A to O and the General Notices; and volume two contains monographs for pharmaceutical substances P to Z, together with those for dosage forms and radiopharmaceutical preparations, the methods of analysis and reagents.
British Pharmaceutical Codex
Author:
Publisher:
ISBN:
Category : Dispensatories
Languages : en
Pages : 1446
Book Description
Publisher:
ISBN:
Category : Dispensatories
Languages : en
Pages : 1446
Book Description
Journal of the American Pharmaceutical Association
Author: American Pharmaceutical Association
Publisher:
ISBN:
Category : Pharmacy
Languages : en
Pages : 100
Book Description
Publisher:
ISBN:
Category : Pharmacy
Languages : en
Pages : 100
Book Description
Pharmacopoeia of the People's Republic of China
Author: Chinese Pharmacopoeia Commission
Publisher:
ISBN: 9780119207798
Category :
Languages : en
Pages :
Book Description
Chinese Pharmacopoeia 2010 is an official and authoritative compendium of drugs. It covers most traditional Chinese medicines, most western medicines and preparations, giving information on the standards of purity, description, test, dosage, precaution, storage, and the strength for each drug. It is published in three volumes, and contains up to 4567 monographs with 1386 new admissions. In Volume I, it contains monographs of Chinese crude drugs and the prepared slices. Vegetable oil/fat and its extract, the patented Chinese traditional medicines, single ingredient of Chinese crude drug preparations etc. it has 2165 monographs with 1019 new admissions (439 articles of the prepared slice) and 634 revised; Volume II deals with monographs of chemical drugs, antibiotics, biochemical preparations, radiopharmaceuticals and excipients for pharmaceutical use, contains 2271 monographs with 330 new admissions and 1500 revised; Volume III contains biological products, has 131 monographs with 37 new admissions and 94 revised
Publisher:
ISBN: 9780119207798
Category :
Languages : en
Pages :
Book Description
Chinese Pharmacopoeia 2010 is an official and authoritative compendium of drugs. It covers most traditional Chinese medicines, most western medicines and preparations, giving information on the standards of purity, description, test, dosage, precaution, storage, and the strength for each drug. It is published in three volumes, and contains up to 4567 monographs with 1386 new admissions. In Volume I, it contains monographs of Chinese crude drugs and the prepared slices. Vegetable oil/fat and its extract, the patented Chinese traditional medicines, single ingredient of Chinese crude drug preparations etc. it has 2165 monographs with 1019 new admissions (439 articles of the prepared slice) and 634 revised; Volume II deals with monographs of chemical drugs, antibiotics, biochemical preparations, radiopharmaceuticals and excipients for pharmaceutical use, contains 2271 monographs with 330 new admissions and 1500 revised; Volume III contains biological products, has 131 monographs with 37 new admissions and 94 revised
Safe and Effective Medicines for Children
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309225493
Category : Medical
Languages : en
Pages : 432
Book Description
The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and PREA and their predecessor policies, as well as assess the incentives for pediatric studies of biologics and the extent to which biologics have been studied in children. The IOM committee concludes that these policies have helped provide clinicians who care for children with better information about the efficacy, safety, and appropriate prescribing of drugs. The IOM suggests that more can be done to increase knowledge about drugs used by children and thereby improve the clinical care, health, and well-being of the nation's children.
Publisher: National Academies Press
ISBN: 0309225493
Category : Medical
Languages : en
Pages : 432
Book Description
The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and PREA and their predecessor policies, as well as assess the incentives for pediatric studies of biologics and the extent to which biologics have been studied in children. The IOM committee concludes that these policies have helped provide clinicians who care for children with better information about the efficacy, safety, and appropriate prescribing of drugs. The IOM suggests that more can be done to increase knowledge about drugs used by children and thereby improve the clinical care, health, and well-being of the nation's children.
The British Pharmacopoeia, 1864 to 2014
Author: Anthony C. Cartwright
Publisher: Routledge
ISBN: 1317039785
Category : History
Languages : en
Pages : 281
Book Description
The British Pharmacopoeia has provided official standards for the quality of substances, medicinal products and articles used in medicine since its first publication in 1864. It is used in over 100 countries and remains an essential global reference in pharmaceutical research and development and quality control. This book explores how these standards have been achieved through a comprehensive review of the history and development of the pharmacopoeias in the UK, from the early London, Edinburgh and Dublin national pharmacopoeias to the creation of the British Pharmacopoeia and its evolution over 150 years. Trade in medicinal substances and products has always been global, and the British Pharmacopoeia is placed in its global context as an instrument of the British Empire as it first sought to cover the needs of countries such as India and latterly as part of its role in international harmonisation of standards in Europe and elsewhere. The changing contents of the pharmacopoeias over this period reflect the changes in medical practice and the development of dosage forms from products dispensed by pharmacists to commercially manufactured products, from tinctures to the latest monoclonal antibody products. The book will be of equal value to historians of medicine and pharmacy as to practitioners of medicine, pharmacy and pharmaceutical analytical chemistry.
Publisher: Routledge
ISBN: 1317039785
Category : History
Languages : en
Pages : 281
Book Description
The British Pharmacopoeia has provided official standards for the quality of substances, medicinal products and articles used in medicine since its first publication in 1864. It is used in over 100 countries and remains an essential global reference in pharmaceutical research and development and quality control. This book explores how these standards have been achieved through a comprehensive review of the history and development of the pharmacopoeias in the UK, from the early London, Edinburgh and Dublin national pharmacopoeias to the creation of the British Pharmacopoeia and its evolution over 150 years. Trade in medicinal substances and products has always been global, and the British Pharmacopoeia is placed in its global context as an instrument of the British Empire as it first sought to cover the needs of countries such as India and latterly as part of its role in international harmonisation of standards in Europe and elsewhere. The changing contents of the pharmacopoeias over this period reflect the changes in medical practice and the development of dosage forms from products dispensed by pharmacists to commercially manufactured products, from tinctures to the latest monoclonal antibody products. The book will be of equal value to historians of medicine and pharmacy as to practitioners of medicine, pharmacy and pharmaceutical analytical chemistry.